Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Jung, Ji Young ^a   Lim, Yeni ^a   Moon, Min Sun ^a   Kim, Ji Yeon ^a   Kwon, Oran ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Antioxidant; Onion Peel Extract; Quercetin; Streptozotocin; Type 2 Diabetes

Indexed keywords

FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN RECEPTOR; INTERLEUKIN 6; MALONALDEHYDE; ONION EXTRACT; QUERCETIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; HYPOGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER; MALE; MUSCLE TISSUE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

ALLIUM CEPA; ANIMALIA; RATTUS;

EID: 79953114290     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-18     Document Type: Article

References (39)

1. Global prevalence of diabetes. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519
2. Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. S Panda A Kar, Biofactors 2007 31 201 210 10.1002/biof.5520310307 18997283 (Pubitemid 352789892)
3. In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. M Aslan D Deliorman Orhan N Orhan E Sezik E Yesilada, J Ethnopharmacol 2007 109 54 59 10.1016/j.jep.2006.07.001 16949229 (Pubitemid 44821670)
4. Hypoglicemic Effect of Leandra lacunosa in normal and alloxan-induced diabetic rats. WR Cunha GM Arantes DS Ferreira R Lucarini ML Silva NA Furtado AA da Silva Filho AE Crotti AR Araujo, Fitoterapia 2008 79 356 360 10.1016/j.fitote.2008.04.002 18538949
5. Influence of dietary capsaicin and onion on the metabolic abnormalities associated with streptozotocin induced diabetes mellitus. PS Babu K Srinivasan, Mol Cell Biochem 1997 175 49 57 10.1023/A:1006881027166 9350033 (Pubitemid 27453335)
6. Type 2 diabetes: principles of pathogenesis and therapy. M Stumvoll BJ Goldstein TW van Haeften, Lancet 2005 365 1333 1346 10.1016/S0140-6736(05)61032- X 15823385
7. The antidiabetic effect of onion and garlic in experimental diabetic rats: meta-analysis. S Kook GH Kim K Choi, J Med Food 2009 12 552 560 10.1089/jmf.2008.1071 19627203
8. Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. A Shetty R Rashmi M Rajan K Sambaiah P Salimath, Nutr Res 2004 24 373 381 10.1016/j.nutres.2003.11.010 (Pubitemid 38739461)
9. Antihyperglycemic potential of natural products. T Matsui LA Ogunwande KJM Abesundara K Matsumoto, Mini-Rev Med Chem 2006 6 109 120 10.2174/138955706776073484 16457635
10. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. AS Dias M Porawski M Alonso N Marroni PS Collado J Gonzalez-Gallego, J Nutr 2005 135 2299 2304 16177186 (Pubitemid 41429581)
11. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. T Mahesh VP Menon, Phytother Res 2004 18 123 127 10.1002/ptr.1374 15022163 (Pubitemid 38380605)
12. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. O Coskun M Kanter A Korkmaz S Oter, Pharmacol Res 2005 51 117 123 10.1016/j.phrs.2004.06.002 15629256 (Pubitemid 40040541)
13. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. M Kobori S Masumoto Y Akimoto Y Takahashi, Mol Nutr Food Res 2009 53 859 868 10.1002/mnfr.200800310 19496084
14. Onions: a source of unique dietary flavonoids. R Slimestad T Fossen IM Vagen, J Agric Food Chem 2007 55 10067 10080 10.1021/jf0712503 17997520
15. Genetic analysis of quercetin in onion (Allium cepa L.) 'Lady Raider'. C Smith KA Lombard EB Peffley W Liu, Texas J Agric Nat Resource 2003 16 24 28
16. Onion flesh and onion peel enhance antioxidant status in aged rats. J Park J Kim MK Kim, J Nutr Sci Vitaminol (Tokyo) 2007 53 21 29 10.3177/jnsv.53.21 17484375 (Pubitemid 46623913)
17. Food content, processing, absorption and metabolism of onion flavonoids. K Nemeth MK Piskula, Crit Rev Food Sci Nutr 2007 47 397 409 10.1080/ 10408390600846291 17457724 (Pubitemid 46676538)
18. The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. M Kanter MF Altan S Donmez A Ocakci ME Kartal, Cell Biochem Funct 2007 25 747 752 10.1002/cbf.1397 17265531 (Pubitemid 351202365)
19. Colorimetry of total phenolics with phosphomolybdic phosphorungstic acid reagents. VL Singleton JA Rossi Jr, Am J Enol Vitic 1965 16 44 158
20. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. MGL Hertog PCH Hollman DP Venema, J Agric Food Chem 1992 40 1591 1598
21. The glycemic index: methodology and clinical implications. TM Wolever DJ Jenkins AL Jenkins RG Josse, Am J Clin Nutr 1991 54 846 854 1951155
22. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
23. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease. AJG Hanley MP Stern K Williams SM Haffner, Diabetes Care 2002 25 1177 1184 10.2337/diacare.25.7.1177 12087016 (Pubitemid 41071169)
24. Determination of glycogen in small tissue samples. S Lo JC Russell AW Taylor, J Appl Physiol 1970 28 234 236 5413312
25. Drugs producing diabetes through damage of the insulin secreting cells. CC Rerup, Pharmacol Rev 1970 22 485 518 4921840
26. Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in liver of type 2 diabetic rats. K Parveen MR Khan M Mujeeb WA Siddiqui, Chem Biol Interact 2010 186 219 227 10.1016/j.cbi.2010.04.023 20433812
27. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. K Srinivasan B Viswanad L Asrat CL Kaul P Ramarao, Pharmacol Res 2005 52 313 320 10.1016/j.phrs.2005.05.004 15979893 (Pubitemid 41175991)
28. Effects of dietary onion (Allium Cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. MS Islam H Choi T Loots du, Ann Nutr Metab 2008 53 6 12 10.1159/000152868 18772584
29. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. J Luo J Quan J Tsai CK Hobensack C Sullivan R Hector GM Reaven, Metabolism 1998 47 663 668 10.1016/S0026-0495(98)90027-0 9627363 (Pubitemid 28265168)
30. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. MJ Reed K Meszaros LJ Entes MD Claypool JG Pinkett TM Gadbois GM Reaven, Metabolism 2000 49 1390 1394 10.1053/meta.2000.17721 11092499
31. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. AD Baron G Brechtel P Wallace SV Edelman, Am J Physiol 1988 255 769 E774 3059816
32. The rat model of type 2 diabetic mellitus and its glycometabolism characters. F Zhang C Ye G Li W Ding W Zhou H Zhu G Chen T Luo M Guang Y Liu D Zhang S Zheng J Yang Y Gu X Xie M Luo, Exp Anim 2003 52 401 407 10.1538/expanim.52.401 14625406 (Pubitemid 41349948)
33. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. O Kwon P Eck S Chen CP Corpe JH Lee M Kruhlak M Levine, FASEB J 2007 21 366 377 10.1096/fj.06-6620com 17172639 (Pubitemid 46213484)
34. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. RA Defronzo D Tripathy, Diabetes Care 2009 32 157 S163 10.2337/dc09-S302 19875544
35. Direct and machrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. PJ Bilan V Samokhvalov A Koshkina JD Schertzer MC Samaan A Klip, Arch Physiol Biochem 2009 115 176 190 10.1080/13813450903079314 19671019
36. Inflammation and metabolic disorders. GS Hotamisligil, Nature 2006 444 860 867 10.1038/nature05485 17167474 (Pubitemid 46024993)
37. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. MT Nguyen S Favelyukis AK Nguyen D Reichart PA Scott A Jenn R Liu-Bryan CK Glass JG Neels JM Olefsky, J Biol Chem 2007 282 35279 35292 10.1074/jbc.M706762200 17916553 (Pubitemid 350232441)
38. Is type II diabetes mellitus a disease of the innate immune system? JC Pickup MA Crook, Diabetologia 1998 41 1241 1248 10.1007/s001250051058 9794114 (Pubitemid 28449093)
39. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. H Kaneto N Katakami M Matsuhisa TA Matsuoka, Mediators Inflamm 2010 2010 1 11 10.1155/2010/453892